Search details
1.
Screening anlotinib responders via blood-based proteomics in non-small cell lung cancer.
FASEB J
; 36(8): e22465, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35867072
2.
Circular RNA EPB41 expression predicts unfavorable prognoses in NSCLC by regulating miR-486-3p/eIF5A axis-mediated stemness.
Cancer Cell Int
; 22(1): 219, 2022 Jun 20.
Article
in English
| MEDLINE | ID: mdl-35725615
3.
Equivalent efficacy assessment of QL1101 and bevacizumab in nonsquamous non-small cell lung cancer patients: A two-year follow-up data update.
Chin J Cancer Res
; 34(1): 28-39, 2022 Feb 28.
Article
in English
| MEDLINE | ID: mdl-35355930
4.
PlGF knockdown attenuates hypoxia-induced stimulation of cell proliferation and glycolysis of lung adenocarcinoma through inhibiting Wnt/ß-catenin pathway.
Cancer Cell Int
; 21(1): 18, 2021 Jan 06.
Article
in English
| MEDLINE | ID: mdl-33407494
5.
Chemometric QSAR modeling of acute oral toxicity of Polycyclic Aromatic Hydrocarbons (PAHs) to rat using simple 2D descriptors and interspecies toxicity modeling with mouse.
Ecotoxicol Environ Saf
; 222: 112525, 2021 Oct 01.
Article
in English
| MEDLINE | ID: mdl-34274838
6.
Serum TNFRII: A promising biomarker for predicting the risk of subcentimetre lung adenocarcinoma.
J Cell Mol Med
; 24(7): 4150-4156, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32073741
7.
Racial differences in characteristics and prognoses between Asian and white patients with nonsmall cell lung cancer receiving atezolizumab: An ancillary analysis of the POPLAR and OAK studies.
Int J Cancer
; 146(11): 3124-3133, 2020 06 01.
Article
in English
| MEDLINE | ID: mdl-31583695
8.
Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Prospective, Single-Arm, Phase II Study.
Oncologist
; 24(2): 157-e64, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30158288
9.
Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for nonsmall cell lung cancer therapy.
Eur Respir J
; 53(3)2019 03.
Article
in English
| MEDLINE | ID: mdl-30578392
10.
Adjuvant Chemotherapy Candidates in Stage I Lung Adenocarcinomas Following Complete Lobectomy.
Ann Surg Oncol
; 26(8): 2392-2400, 2019 Aug.
Article
in English
| MEDLINE | ID: mdl-31011907
11.
Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer.
PLoS Genet
; 12(4): e1005895, 2016 Apr.
Article
in English
| MEDLINE | ID: mdl-27093186
12.
Pretreatment direct bilirubin and total cholesterol are significant predictors of overall survival in advanced non-small-cell lung cancer patients with EGFR mutations.
Int J Cancer
; 140(7): 1645-1652, 2017 04 01.
Article
in English
| MEDLINE | ID: mdl-28006834
13.
Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial.
Int J Cancer
; 141(6): 1249-1256, 2017 09 15.
Article
in English
| MEDLINE | ID: mdl-28560853
14.
Transcriptional profiling revealed the anti-proliferative effect of MFN2 deficiency and identified risk factors in lung adenocarcinoma.
Tumour Biol
; 37(7): 8643-55, 2016 Jul.
Article
in English
| MEDLINE | ID: mdl-26733181
15.
The association between the polymorphisms in a sodium channel gene SCN7A and essential hypertension: a case-control study in the Northern Han Chinese.
Ann Hum Genet
; 79(1): 28-36, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25393565
16.
Placental growth factor promotes metastases of non-small cell lung cancer through MMP9.
Cell Physiol Biochem
; 37(3): 1210-8, 2015.
Article
in English
| MEDLINE | ID: mdl-26418253
17.
Association of cholesteryl ester transfer protein (CETP) gene polymorphism, high density lipoprotein cholesterol and risk of coronary artery disease: a meta-analysis using a Mendelian randomization approach.
BMC Med Genet
; 15: 118, 2014 Oct 23.
Article
in English
| MEDLINE | ID: mdl-25366166
18.
MMP9 activation triggered by epidermal growth factor induced FoxO1 nuclear exclusion in non-small cell lung cancer.
Tumour Biol
; 35(7): 6673-8, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24705809
19.
Vitamin D inhibition of lung adenocarcinoma cell proliferation in vitro.
Tumour Biol
; 35(11): 10953-8, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25087094
20.
IGF-1R and Bmi-1 expressions in lung adenocarcinoma and their clinicopathologic and prognostic significance.
Tumour Biol
; 35(1): 739-45, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-23990442